Safe use of sodium glucose co-transporter 2 inhibitors in the management of type 2 diabetes
No Thumbnail Available
Authors
Noble-Bell, Georgia
Bright-Davies, Comfort
Check for full-text access
Issue Date
2023
Type
Article
Language
Keywords
Alternative Title
Abstract
One class of oral medicines used in the management of type 2 diabetes is sodium glucose co-transporter 2 (SGLT2) inhibitors. Their mode of action is unique and is not dependent on beta-cell function or the degree of a person's insulin resistance. This article reviews the use of SGLT2 inhibitors in managing type 2 diabetes, explaining the potential benefits and side effects of these medicines. It also explains the role of healthcare professionals, including nurses, in ensuring these medicines are used safely and appropriately.
Description
Citation
Publisher
License
Journal
Nursing Standard
Volume
38
Issue
1